N. Farman

Discipline

Psychologie (1)

Type de document

Co-auteur

M. Zhao

F. Behar-Cohen

F. Jaisser

E. Bousquet

M.C. Naud

X. Xie

M. Seminel

P.R. Rothschild

C. Rivolta

A. Prunotto

A. Matet

I. Mantel

A. Ly

X. Li

R. Levy-Boukris

G. Leroux Les Jardins

S. Lechner

L. Jonet

R. Herrero-Vanrell

B. Goldenberg

E. Gélizé

A. Gaudric

A. Dirani

M. Dernigoghossian

Y. de Kozak

A. Daruich

B. Couraud

F. Chast

J. Canonica

I. Bravo-Osuna

M.L. Brandely

T. Beydoun

B. Besson-Lescure

C. Bergin

R. Batista

A. Arboleda

C. Andrieu-Soler

Date

Source

Serveur académique Lausannois (4)

Mot-clé

thérapie (4) Treatment (4) Therapeutics (4) Human beings (4) Patients (3) Animals (3) Use (3) Patients (3) Spironolactone (2) Rats (2) Injections (2) Eye (2) Expression (2) Aldosterone (2) Older people (2) Receptors (2) roman (2) administration (1) stress psychologique (1) protéine (1) organe (1) modèle (1) plomb (1) antagonisme (1) animal (1) analyse (1) épidémiologie (1) enzyme (1) effet (1) dosage (1)

Documents écrit par N. Farman (4) | parle de N. Farman (0)

Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.

M. Zhao et al. (21 janv. 2019)

SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY.

E. Bousquet et al.

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

A. Daruich et al. (2015)

The aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitis.

E. Bousquet et al. (2012)